About 10 000 reports

  • Total Monoclonal Antibody Sales Volume (Million
  • Share (Million Yuan)

Autoimmunity Diseases Treatment Antibody is one important Monoclonal Antibody in China.

  • Healthcare
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Share (Million Yuan)
  • Autoimmunity Diseases Treatment Antibody Sales

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Monoclonal Antibody in China is growing rapidly.

  • Healthcare
  • Targeted Therapy
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials Executive Summary Chapter ## – Introduction Chapter ## – Trends in Cancer monoclonal antibody dealmaking ##. ##.

  • Cancer
  • Healthcare
  • Monoclonal Antibody
  • United States
  • Demand

Ado-trastuzumab emtansine (Kadcyla, ), an antibody that targets HER##, attaches itself to a chemo drug called Myotonic dystrophy type ## (DM##).

  • Healthcare
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • LIST OF ABBREVIATIONS

ADCETRIS is a chimeric monoclonal immunoglobulin (Ig)G## antibody, which acts against CD## expressed in HL and systemic anaplastic large cell lymphoma.

  • Healthcare
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Figure ##: Overview of the Development Pipeline in SMA Monoclonal Antibody Fast Skeletal Muscle Troponin Activator SRK-## Figure ##: Key Trials for the Promising Pipeline Agents that GlobalData Expects to Be Licensed for © GlobalData TABLE ## PROVIDES THE COMPARISON OF DIFFERENT TH

  • Healthcare
  • Neurological Disorder
  • United States
  • World
  • Forecast
  • Global Monoclonal Antibodies Market, 2017, By Source

METABOLIC MONOCLONAL ANTIBODIES THIRD ONE?

  • Healthcare
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • SWOT ANALYSIS: ADUCANUMAB, FIRST MONOCLONAL ANTIBODY TO ENTER THE AD MARKET
  • Ongoing Phase III trials, which could confirm aducanumab's effect in a larger prodromal AD population.

" I' m intrigued by the anti-tau monoclonal antibodies.

  • Healthcare
  • United States
  • Eisai Co., Ltd.
  • Novartis AG
  • Roche Group
  • Global Monoclonal Antibodies Market, 2017, By Source

METABOLIC MONOCLONAL ANTIBODIES THIRD ONE?

  • Healthcare
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Global Monoclonal Antibody Sterile Injectables Market
  • Global Monoclonal Antibody Sterile Injectables Market

Monoclonal Antibody Insulin Vaccines Fusion Proteins Immunoglobulins Others ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% Source: Azoth Analytics Estimates Global Monoclonal Antibody Sterile Injectables Market Market Size, By Value, 2013-2017 (USD Billion) Figure ##: Global

  • Healthcare
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • D) Pemphigus vulgaris
  • F) Cutaneous lupus erythematosus

For example, anti-fibrillin-## antibodies can activate fibroblasts, and antibodies to matrix metalloproteinase-## (MMP-##) and MMP-## can prevent the breakdown of excessive collagen.

  • Healthcare
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.

In 2008, monoclonal antibody sales were only ##. ## billion Yuan.

  • Diagnostics
  • Healthcare
  • Interferon
  • China
  • Demand
  • IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND
  • IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

The total sales volume of monoclonal antibody reached ## million Yuan in 2018.

  • Healthcare
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND
  • Kidney Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification in 2018 (Million Yuan/percent)

Monoclonal antibodies are genetically engineered antibodies that are identical copies of one another.

  • Healthcare
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • CARDIOVASCULAR DISEASE DRUGS, GLOBAL, CLINICAL TRIAL DURATION BY STAGE OF DEVELOPMENT AND MOLECULE TYPE (MONTHS), 2006-2017
  • C) Phase III

Sanofi' s Praluent, a PCSK## inhibitor, was also approved in 2015 and is a monoclonal antibody (mAb) antidyslipidemic with high revenue potential.

  • Healthcare
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Pfizer Inc.

TAKEDA PHARMACEUTICALS Chapter ## Appendix Acronyms List of Tables Summary Table : Global Colorectal Cancer Therapeutics Market, by Treatment Type, Through 2023 Table ## : U. S.

  • Healthcare
  • Therapy
  • World
  • Forecast
  • Market Size

Global Laboratory Reagents Industry LABORATORY REAGENTS MCP-## MARKET ANALYSIS, TRENDS, AND FORECASTS, MAY ## CONTENTS ##.

  • Healthcare
  • APAC
  • Japan
  • United States
  • World

Immune response-based strategies like monoclonal antibodies, brain cancer vaccines and oncolytic viral therapies are in clinical trials and are expected to offer enormous potential for growth in this market.

  • Brain Cancer
  • Healthcare
  • Therapy
  • World
  • BRONCHODILATORS MARKET IN APAC

Xolair was the only monoclonal antibody approved for the treatment of allergic asthma in APAC, until the approval of GlaxoSmithKline' s mepolizumab in early 2016.

  • Healthcare
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

In 2008, monoclonal antibody sales were only ##. ## billion Yuan.

  • Healthcare
  • China
  • Demand
  • Market Size
  • Dongguan Winnerway Bio-Tech Co., Ltd.
  • PRODUCT PROFILE - ERENUMAB (AMG-334)
  • UNMET NEED AND OPPORTUNITY IN EPISODIC AND CHRONIC MIGRAINE, 2017

" CGRP monoclonal antibodies are an incredible development.

  • Healthcare
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Sales Forecast by Class for Multiple Myeloma in Japan in 2017 and 2027
  • Sales Forecast by Class for Multiple Myeloma in the 5EU in 2017 and 2027

ADDITIONAL ADD-ON THERAPIES IN THE FORM OF MONOCLONAL ANTIBODIES HAVE ENTERED THE MARKET IN RECENT YEARS.

  • Healthcare
  • East Asia
  • United States
  • Demand
  • Forecast
  • MARSTACIMAB
  • provides an assessment of Pfizer's hemophilia portfolio.

Hemlibra is a bispecific monoclonal antibody that mimics FVIII by targeting FIXa and FX to promote coagulation.

  • Healthcare
  • Novo Nordisk Group
  • Pfizer Inc.
  • Roche Group
  • Takeda Pharmaceutical Company Limited

Monoclonal antibodies - Market size and forecast 2018-2023 Vaccines - Market size and forecast 2018-2023 Cell and gene therapy - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by product PART ##: CUSTOMER LANDSCAPE PART ##: GEOGRAP

  • Cancer
  • Healthcare
  • Medical Biotechnology
  • World
  • Forecast

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions Chapter ## Introduction Study Goals and Objectives Scope of Report Information Sources Methodology Market Estimation and Forecast Geographic Breakdown Analyst’s Credentials BCC Custom Research Related BCC Resea

  • Cancer
  • Healthcare
  • Pathology
  • Therapy
  • World
  • Epilepsy Therapeutics Market, Global, Co-development Deals by Molecule Type and
  • A) Number of deals by phase and molecule type

As shown in Figure ##D, the ' other biologics' category is made up of antisense oligonucleotide with six products, gene therapy with two products, fusion protein, recombinant peptide, cell therapy and antibody with one product each.

  • Healthcare
  • Mental Health
  • Market Size
  • Eisai Co., Ltd.
  • GW Pharmaceuticals plc
  • NOVARTIS' PCA PORTFOLIO ASSESSMENT, 2019
  • PROVIDES AN ASSESSMENT OF NOVARTIS' PCA PORTFOLIO.

THE COMPANY ALSO HAS SIX DRUGS IN PHASE II AND FIVE IN PHASE I FOR PROSTATE CANCER, WITH SMALL MOLECULES, MONOCLONAL ANTIBODIES (MABS), AND RADIOLABELLED AGENTS COVERING MULTIPLE MOAS.

  • Healthcare
  • East Asia
  • United States
  • Forecast
  • Pfizer Inc.

Portable Oxygen Concentrators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 ##.

  • Healthcare
  • Oxygen Device
  • APAC
  • World
  • Forecast

Anti-PD-## Monoclonal Antibodies ##. ##. ##.

  • Ear, Nose, And Throat Medicine
  • Health Services
  • Healthcare
  • World
  • Market Size

There are several drug approvals for lymphoma involving drug targets as antibody-drug conjugates, programmed death-## receptor/ programmed death ligands and microtubules, among others.

  • Cancer
  • Healthcare
  • Leukemia
  • Pathology
  • World